Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oncology
oncology
An AbbVie clinical vet heading early oncology jumps ship to build his own team at NK cell-focused biotech
Endpoints
Tue, 05/11/21 - 11:10 am
Thorsten Graef
Pharmacyclics
AbbVie
oncology
Acepodia
NK cells
Another 5 years of dominance: Oncology, immunology will extend their lead as pharma's top fields through 2025
Fierce Pharma
Fri, 05/7/21 - 10:39 am
biosimilars
oncology
immunology
autoimmune disease
cancer
Trillium unveils CD47 clinical research priorities as investors await solid tumor data
Fierce Biotech
Wed, 04/28/21 - 10:52 am
Trillium Therapeutics
CD47
solid tumors
oncology
cancer
GlaxoSmithKline culls early-stage Immunocore med as well as DMD asset in Q1 clear-out
Fierce Biotech
Wed, 04/28/21 - 10:47 am
GSK
oncology
Immunocore
Duchenne Muscular Dystrophy
What are Merck, Bristol Myers and Roche planning for the big FDA cancer approval review?
Fierce Pharma
Tue, 04/27/21 - 11:04 am
FDA
oncology
accelerated approvals
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
FDA Advisory Committee to Review Checkpoint Inhibitors Greenlit Under Accelerated Approval
BioSpace
Sun, 04/25/21 - 01:56 pm
FDA
oncology
cancer
accelerated approvals
Bristol Myers Squibb
Opdivo
Roche
Tecentriq
Merck
Keytruda
Sponsors should flag decentralized aspects of cancer trials to prep for the post-Covid era, FDA says
Endpoints
Thu, 04/15/21 - 10:01 am
FDA
oncology
clinical trials
decentralized clinical trials
Boehringer’s big cancer reveal draws near
EP Vantage
Mon, 03/29/21 - 10:27 am
Boehringer Ingelheim
AACR
cancer
oncology
KRAS
José Baselga, acclaimed drug hunter, physician and AstraZeneca's pioneering cancer R&D chief, has died
Endpoints
Sun, 03/21/21 - 11:53 pm
Jose Baselga
AstraZeneca
R&D
oncology
How Five Prime suitor Amgen battled multiple companies for the biotech—and won
Fierce Biotech
Fri, 03/19/21 - 10:48 am
Amgen
M&A
Five Prime Therapeutics
SEC
oncology
Xilio raises $95M to take twists on Yervoy and IL-2 into clinic
Fierce Biotech
Wed, 02/24/21 - 10:57 am
Xilio Therapeutics
funding
immunotherapy
clinical trials
cancer
oncology
Yervoy
AstraZeneca drops breast, prostate cancer programs in Q4 pipeline cull
Fierce Biotech
Thu, 02/11/21 - 10:34 am
AstraZeneca
oncology
AZD9496
breast cancer
imaradenant
prostate cancer
Amgen slams the brakes on a clutch of cancer drugs as reality BiTEs
Fierce Biotech
Wed, 02/3/21 - 10:45 am
Amgen
earnings
cancer
oncology
drug development
Why Cardiff Oncology Ran Up 1,350% in 2020
Motley Fool
Sun, 01/31/21 - 10:11 pm
Cardifff Oncology
oncology
cancer
KRAS mutation
Go or no go? Oncology decisions ahead for the FDA
EP Vantage
Wed, 01/27/21 - 11:55 am
FDA
cancer
oncology
Bristol-Myers Squibb
TG Therapeutics
Mallinckrodt
Sanofi
Regeneron
Sarepta Therapeutics
GSK
Oncopeptide
Kura Oncology’s Small Molecules Hint at Major Therapeutic Breakthroughs
BioSpace
Wed, 01/20/21 - 11:20 pm
cancer
oncology
Kura Oncology
personalized medicine
The Future of Cancer Treatment Lies in Vaccines, Say These Pioneers
BioSpace
Wed, 01/20/21 - 11:19 pm
cancer
oncology
vaccines
cancer vaccines
Neuvogen
Lineage Therapeutics
BioNTech
Eli Lilly tees up discovery pact worth more than $1.6B with Merus for T cell-focused bispecific antibodies
Endpoints
Tue, 01/19/21 - 10:39 am
Eli Lilly
oncology
Merus
drug discovery
Two Cancer Companies Close Series A Rounds Netting $144 Million
BioSpace
Wed, 01/13/21 - 11:38 pm
cancer
oncology
funding
Delfi Diagnostics
Elucida Oncology
JPM: Bluebird to spin off cancer therapies into new company
Fierce Biotech
Mon, 01/11/21 - 10:26 am
Bluebird Bio
spinoffs
oncology
JPMHC 2021
Oncology Newco
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »